We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Ranked Momentum Stocks to Buy for January 23rd
Read MoreHide Full Article
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 23rd:
BioTelemetry, Inc. (BEAT - Free Report) : This fashion and lifestyle products retailer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25% over the last 60 days.
ABIOMED, Inc. : This developer and seller of medical devices has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.
AC Immune SA (ACIU - Free Report) : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 50.6% over the last 60 days.
In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?
From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.
This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for January 23rd
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 23rd:
BioTelemetry, Inc. (BEAT - Free Report) : This fashion and lifestyle products retailer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25% over the last 60 days.
BioTelemetry, Inc. Price and Consensus
BioTelemetry, Inc. price-consensus-chart | BioTelemetry, Inc. Quote
BioTelemetry’s shares gained 5.2% over the last one month more than S&P 500’s gain of 12.7%. The company possesses a Momentum Score of B.
BioTelemetry, Inc. Price
BioTelemetry, Inc. price | BioTelemetry, Inc. Quote
ABIOMED, Inc. : This developer and seller of medical devices has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.
ABIOMED, Inc. Price and Consensus
ABIOMED, Inc. price-consensus-chart | ABIOMED, Inc. Quote
ABIOMED’s shares gained 9.3% over the last one month. The company possesses a Momentum Score of A.
ABIOMED, Inc. Price
ABIOMED, Inc. price | ABIOMED, Inc. Quote
AC Immune SA (ACIU - Free Report) : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 50.6% over the last 60 days.
AC Immune SA Price and Consensus
AC Immune SA price-consensus-chart | AC Immune SA Quote
AC Immune’s shares gained 12.7% over the last one month. The company possesses a Momentum Score of B.
AC Immune SA Price
AC Immune SA price | AC Immune SA Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?
From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.
This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.
See Stocks Today >>